Target Serum Urate: Do Gout XXXX Know Their Goal?

@entity1 @entity210 @entity208 @entity414
OBJECTIVE: To examine @entity210 @entity1 ' knowledge of their condition, including the central role of achieving and maintaining serum urate (SU) goal with the use of @entity414 lowering therapy (ULT). METHODS: This study of 612 @entity210 @entity1 was conducted at a Veterans Affairs medical center. Gout @entity1 were included based on administrative diagnostic codes and receipt of at least one @entity208 prescription over a one-year period. Questionnaires were mailed to @entity1 and linked to medical records data. The questionnaire included @entity210 -specific knowledge questions, the @entity1 Activation Measure and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses. RESULTS: The questionnaire had a 62% response rate. Only 14% of @entity1 knew their SU goal while the vast majority answered correctly for the other 5 @entity210 -specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (OR 3.0; 95% CI 1.4 to 6.2) and knowing all of the other 5 @entity210 -specific knowledge questions (OR 2.1; 95% CI 1.3 to 3.4) were associated with greater odds of knowing SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or @entity210 -specific health status. CONCLUSION: There is a knowledge deficit regarding SU treatment goal among @entity210 @entity1 receiving ULT despite generally high levels of other @entity210 -specific knowledge. SU goal information may be an important and underutilized concept among providers treating @entity210 @entity1 . This article is protected by copyright. All rights reserved.
